IFI-M · PUA Tri-Axis Balanced Series

Specimen SS-F-M3-01304 // MULTI-AXIS · IFI-M

PUA Tri-Axis Balanced Series I-IV

Brassica nigra

Black Mustard

Tier IPUA Tri-Axis Balanced Series

Target Trait

1×

fold-change

Sharp+Umami+Astringency balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01304

Genomic Edits

5

GC Content

44.3%

Construct Length

3,913 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + mGluR1 + Polyphenol-astringency axis

IFI Score

100

Pathway Edits

  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent PUA pathway operation
  • Cross-pathway regulatory circuit for balanced PUA triple-axis expression

Key Interventions

Triple-axis receptor co-activation: TRPA1, mGluR1, and Polyphenol-astringency axis pathways simultaneously engineeredBalanced tri-axis expression strategy (PUA) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I PUA triple-axis construct for advanced multi-modal sensory architecture combining sharp, umami, and astringency axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?